| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Oyler John is a Chief Executive Officer at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 92 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2020 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 4,635 | $141.43 | $655,537.37 | -38.4% | |
| Dec 17, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 62,259 | $160.62 | $10,000,099.87 | -33.0% | |
| Jul 8, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 3,106 | $126.87 | $394,055.49 | -49.3% | |
| May 1, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 2,824 | $125.18 | $353,504.52 | -65.7% | |
| Mar 6, 2019 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 25,499 | $151.73 | $3,868,938.48 | -56.9% | |
| Dec 10, 2018 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 4,138 | $135.78 | $561,862.99 | -32.2% | |
| Nov 28, 2018 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 29,195 | $143.66 | $4,194,035.36 | -6.9% | |
| Jul 16, 2018 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 2,550 | $164.12 | $418,497.33 | -100% | |
| Mar 2, 2018 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 99,000 | $145.63 | $14,416,930.90 | -7.9% | |
| Dec 26, 2017 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 20,137 | $96.46 | $1,942,514.80 | -3.8% |